Abstract
A recent large epidemiological study found fluoroquinolone use is associated with an increased risk of aortic aneurysm or dissection. We aimed to examine fluoroquinolone (ciprofloxacin, levofloxacin and moxifloxacin) associated aortic aneurysm or dissection through data mining of the US Food and Drug Administration Adverse Event Reporting System (FAERS). Reports to the FAERS from 1 January 2004 to 31 December 2016 were analysed. Pharmacovigilance tools were used for quantitative detection of signals that is, drug-associated adverse events, including reporting odds ratio, proportional reporting ratio, information component given by a Bayesian confidence propagation neural network and empirical Bayes geometric mean. Sensitivity analyses that limited the data by gender and adverse event date also showed similar trends. Based on 3721 adverse event reports, all three fluoroquinolones are associated with aortic aneurysm, and levofloxacin is associated with aortic dissection. The risk of aortic aneurysm is higher than the aortic dissection. Oral administration of fluoroquinolones is more likely to produce these adverse events. The results obtained herein are consistent with clinical observations, suggesting the necessity for further c...Continue Reading
References
Aug 11, 1998·European Journal of Clinical Pharmacology·A BateR M De Freitas
Feb 7, 2002·Pharmacoepidemiology and Drug Safety·S J EvansS Davis
May 10, 2002·Pharmacoepidemiology and Drug Safety·Eugène P van PuijenbroekAntoine C G Egberts
Jun 20, 2002·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Ana SzarfmanRobert T O'Neill
May 27, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Yasmin Khaliq, George G Zhanel
Feb 12, 2008·Human Pathology·Luciano de Figueiredo BorgesPaulo Sampaio Gutierrez
Jul 18, 2008·BMJ : British Medical Journal·Janice Hopkins Tanne
Feb 4, 2009·Drug Discovery Today·M Hauben, A Bate
Apr 10, 2009·Pharmacoepidemiology and Drug Safety·A Bate, S J W Evans
Jul 6, 2010·Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society·Wen-Chung TsaiJong-Hwei S Pang
Sep 1, 2011·Statistical Methods in Medical Research·Ivan ZorychAndrew Bate
Sep 8, 2011·International Journal of Medical Sciences·Toshiyuki SakaedaYasushi Okuno
Dec 30, 2011·PloS One·Toshiyuki SakaedaYasushi Okuno
Nov 20, 2015·BMJ Open·Nick DanemanDonald A Redelmeier
Jan 15, 2016·Applied Clinical Informatics·P Yildirim
Jul 26, 2017·The American Journal of Medicine·Sonal Singh, Amit Nautiyal
Jan 13, 2018·JAMA Oncology·Yasuo OshimaArinobu Tojo
Mar 10, 2018·BMJ : British Medical Journal·Björn PasternakHenrik Svanström
Jul 27, 2018·JAMA Surgery·Scott A LeMaireYing H Shen
Oct 13, 2018·International Journal of Cardiology·Anas T NomanAref A Bin Abdulhak
Citations
Jun 19, 2020·Journal of Clinical Medicine·Anand Prakash SinghHind Lal
Aug 29, 2020·VASA. Zeitschrift für Gefässkrankheiten·Sigrid NikolChristine Espinola-Klein
Mar 18, 2020·Scientific Reports·Jing HuangHong Chen
Feb 6, 2020·BMC Cardiovascular Disorders·Xiao-Ce DaiHui-Lin Hu
Feb 18, 2021·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Justin C TosseyLynn C Wardlow
Apr 16, 2021·British Journal of Clinical Pharmacology·Jeresa I A WillemsDaan J L van Twist
Apr 29, 2021·International Journal of Clinical Practice·Caibing XuWei Fang
May 28, 2021·Scientific Reports·Ian WeeAndrew M T L Choong
Jul 16, 2021·JGH Open : an Open Access Journal of Gastroenterology and Hepatology·Mohamed Kadry TaherDaniel Krewski
Jul 15, 2021·Expert Opinion on Drug Safety·Vijay KumarJong-Joo Kim
Sep 30, 2021·BMC Cardiovascular Disorders·Cui Jun, Bian Fang
Oct 14, 2021·Expert Opinion on Drug Safety·Mohamed Kadry TaherDaniel Krewski
Nov 13, 2020·Seminars in Thoracic and Cardiovascular Surgery·Nuno Vouga RibeiroDaniel Caldeira
Dec 18, 2021·Expert Opinion on Drug Safety·Yamin ShuQilin Zhang